Literature DB >> 16501125

Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region.

Jeremy O Jones1, Marvin Sommer, Shaye Stamatis, Ann M Arvin.   

Abstract

The varicella-zoster virus (VZV) ORF62/63 intergenic region was cloned between the Renilla and firefly luciferase genes, which acted as reporters of ORF62 and ORF63 transcription, and recombinant viruses were generated that carried these reporter cassettes along with the intact native sequences in the repeat regions of the VZV genome. In order to investigate the potential contributions of cellular transregulatory proteins to ORF62 and ORF63 transcription, recombinant reporter viruses with mutations of consensus binding sites for six proteins within the intergenic region were also created. The reporter viruses were used to evaluate ORF62 and ORF63 transcription during VZV replication in cultured fibroblasts and in skin xenografts in SCIDhu mice in vivo. Mutations in putative binding sites for heat shock factor 1 (HSF-1), nuclear factor 1 (NF-1), and one of two cyclic AMP-responsive elements (CRE) reduced ORF62 reporter transcription in fibroblasts, while mutations in binding sites for HSF-1, NF-1, and octamer binding proteins (Oct-1) increased ORF62 reporter transcription in skin. Mutations in one CRE and the NF-1 site altered ORF63 transcription in fibroblasts, while mutation of the Oct-1 binding site increased ORF63 reporter transcription in skin. The effect of each of these mutations implies that the intact binding site sequence regulates native ORF62 and ORF63 transcription. Mutation of the only NF-kappaB/Rel binding site had no effect on ORF62 or ORF63 transcription in vitro or in vivo. The segment of the ORF62/63 intergenic region proximal to ORF63 was most important for ORF63 transcription, but mutagenesis also altered ORF62 transcription, indicating that this region functions as a bidirectional promoter. This first analysis of the ORF62/63 intergenic region in the context of VZV replication indicates that it is a dual promoter and that cellular transregulatory factors affect the transcription of these key VZV regulatory genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501125      PMCID: PMC1395429          DOI: 10.1128/JVI.80.6.3116-3121.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR.

Authors:  R J Cohrs; J Randall; J Smith; D H Gilden; C Dabrowski; H van Der Keyl; R Tal-Singer
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters.

Authors:  Bretton C Summers; David A Leib
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus.

Authors:  Jeremy O Jones; Ann M Arvin
Journal:  Antiviral Res       Date:  2005-08-09       Impact factor: 5.970

Review 5.  What is a cAMP response unit?

Authors:  W J Roesler
Journal:  Mol Cell Endocrinol       Date:  2000-04-25       Impact factor: 4.102

6.  Phosphorylation of varicella-zoster virus IE63 protein by casein kinases influences its cellular localization and gene regulation activity.

Authors:  Sébastien Bontems; Emmanuel Di Valentin; Laurence Baudoux; Bernard Rentier; Catherine Sadzot-Delvaux; Jacques Piette
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

Review 7.  Varicella-zoster virus: molecular virology and virus-host interactions.

Authors:  A M Arvin
Journal:  Curr Opin Microbiol       Date:  2001-08       Impact factor: 7.934

8.  Physical and functional interaction between the varicella zoster virus IE63 and IE62 proteins.

Authors:  Jennifer M Lynch; Terri K Kenyon; Charles Grose; John Hay; William T Ruyechan
Journal:  Virology       Date:  2002-10-10       Impact factor: 3.616

9.  Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy.

Authors:  C Amici; G Belardo; A Rossi; M G Santoro
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

10.  Interactions among structural proteins of varicella zoster virus.

Authors:  M Spengler; N Niesen; C Grose; W T Ruyechan; J Hay
Journal:  Arch Virol Suppl       Date:  2001
View more
  16 in total

1.  A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein.

Authors:  Mohamed I Khalil; Ann Arvin; Jeremy Jones; William T Ruyechan
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo.

Authors:  Xibing Che; Barbara Berarducci; Marvin Sommer; William T Ruyechan; Ann M Arvin
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  An Sp1/Sp3 site in the downstream region of varicella-zoster virus (VZV) oriS influences origin-dependent DNA replication and flanking gene transcription and is important for VZV replication in vitro and in human skin.

Authors:  Mohamed I Khalil; Makeda Robinson; Marvin Sommer; Ann Arvin; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

4.  Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis.

Authors:  Nandini Sen; Xibing Che; Jaya Rajamani; Leigh Zerboni; Phillip Sung; Jason Ptacek; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-21       Impact factor: 11.205

5.  Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo.

Authors:  Jeremy O Jones; Ann M Arvin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Varicella-zoster virus (VZV) origin of DNA replication oriS influences origin-dependent DNA replication and flanking gene transcription.

Authors:  Mohamed I Khalil; Marvin H Sommer; John Hay; William T Ruyechan; Ann M Arvin
Journal:  Virology       Date:  2015-03-17       Impact factor: 3.616

7.  Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.

Authors:  Sylvie François; Nandini Sen; Bryan Mitton; Xiangshu Xiao; Kathleen M Sakamoto; Ann Arvin
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

8.  Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.

Authors:  Stefan L Oliver; Leigh Zerboni; Marvin Sommer; Jaya Rajamani; Ann M Arvin
Journal:  J Virol Methods       Date:  2008-09-24       Impact factor: 2.014

9.  Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.

Authors:  Nadia El Mjiyad; Sébastien Bontems; Geoffrey Gloire; Julie Horion; Patricia Vandevenne; Emmanuel Dejardin; Jacques Piette; Catherine Sadzot-Delvaux
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

10.  The phosphorylation profile of protein kinase A substrates is modulated during Varicella-zoster virus infection.

Authors:  Nathalie Desloges; Markus Rahaus; Manfred H Wolff
Journal:  Med Microbiol Immunol       Date:  2007-12-08       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.